Genetic Study Reveals Divergent Causal Impacts of IL6 and IL6R Biomarkers on Long-Term Human Mortality

A study of 750,000 people finds IL6 increases mortality while IL6R reduces it. Learn how these biomarkers causally impact cardiovascular health and longevity.

By: AXL Media

Published: Feb 27, 2026, 10:13 AM EST

Source: The information in this article was sourced from Impact Journals LLC

Decoding the Inflammatory Drivers of Longevity

New research has illuminated the complex relationship between chronic inflammation and human lifespan by identifying distinct causal roles for specific biomarkers. Led by Eliano P. Navarese of Link Campus University and the SIRIO MEDICINE Research Network, the study utilized Mendelian randomization to evaluate how genetically proxied levels of inflammatory markers influence long-term survival. Unlike traditional observational studies that may conflate correlation with causation, this genetic approach allowed researchers to isolate the specific impact of biomarkers on mortality over a median follow-up period of nearly twelve years.

The Contrasting Survival Signals of IL6 and IL6R

The analysis revealed a striking biological opposition between Interleukin-6 (IL6) and its soluble receptor (IL6R). According to the study data, genetically higher levels of IL6 were associated with a 5% increase in all-cause mortality. Conversely, elevated levels of IL6R were linked to a 5% reduction in mortality risk. This divergence suggests that while IL6 serves as a driver of systemic damage, higher circulating IL6R may act as a protective buffer, potentially dampening the harmful inflammatory signaling that typically accelerates vascular aging and organ decay.

Cardiovascular Mechanisms Behind the Protective Signal

The protective effects associated with higher IL6R levels extended beyond general survival to specific clinical endpoints. Researchers found that individuals with the genetic proxy for elevated IL6R had a significantly lower risk of developing atrial fibrillation, coronary artery disease, and stroke. The data suggests that IL6R modulation influences the health of the myocardium and vessel walls, offering a safeguard against the primary causes of cardiovascular death. Furthermore, a reduced risk of lung cancer was also observed, hinting at broader systemic benefits of modulating this specific inflammatory pathway.